Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/219512
Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Objectives: Cannabidiol (CBD) is a phytocannabinoid with great potential in clinical applications. The mechanism(s) of action of CBD require further investigation. Previous studies suggested that adenosine A2A receptors (A2ARs) could play a role in CBD-induced effects. Here, we evaluated the ability of CBD to modify the function of A2AR. Methods: We used HEK-293T cells transfected with the cDNA encoding the human A2AR and Gαs protein, both modified to perform bioluminescence-based assays. We first assessed the effect of CBD on A2AR ligand binding using an A2AR NanoLuciferase sensor. Next, we evaluated whether CBD modified A2AR coupling to mini-Gαs proteins using the NanoBiT™ assay. Finally, we further assessed CBD effects on A2AR intrinsic activity by recording agonist-induced cAMP accumulation.
Results: CBD did not bind orthosterically to A2AR but reduced the coupling of A2AR to Gαs protein and the subsequent generation of cAMP. Conclusion: CBD negatively modulates A2AR functioning.
Subject
Subject (English)
Citation
Citation
SÁNCHEZ FERNÁNDEZ, Nuria, et al. Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells. Acta Neuropsychiatrica. 2024. Vol. 36, num. 5, pags. 320-324. ISSN 0924-2708. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/219512